Supplementation of Galatonol 300 mg / Striatin 30 mg in Postpartum Lactating Mothers

PHASE3RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

October 21, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Lactation Induced
Interventions
DRUG

Galatonol 300 mg/Striatin 30 mg

1 film-coated caplet of Herba Asimor, twice daily

DRUG

Placebo

1 film-coated caplet of placebo Herba Asimor, twice daily

Trial Locations (10)

Unknown

RECRUITING

Klinik Pratama Anugrah Sleman, Sleman

RECRUITING

Private Midwife Practice (Bidan Anisa), Sleman

RECRUITING

Private Midwife Practice (Bidan Catur), Sleman

RECRUITING

Private Midwife Practice (Bidan Istri Utami), Sleman

RECRUITING

Private Midwife Practice (Bidan Istri Yuliani), Sleman

RECRUITING

Private Midwife Practice (Bidan Kisti), Sleman

RECRUITING

Private Midwife Practice (Bidan Mei), Sleman

RECRUITING

Private Midwife Practice (Bidan Tutik), Sleman

RECRUITING

Private Midwife Practice (Bidan Wati), Sleman

RECRUITING

Private Midwife Practice (Bidan Widya), Sleman

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Dexa Medica Group

INDUSTRY

NCT06558071 - Supplementation of Galatonol 300 mg / Striatin 30 mg in Postpartum Lactating Mothers | Biotech Hunter | Biotech Hunter